DEA lifts restrictions on GE imaging agent; Terumo invests in Dutch startup Quirem;

@FierceMedDev: ShiftLab's first device is nearing commercialization. Will it start a low-cost revolution? More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Robotic surgery aspirant receives $4M+ in equity financing. Article | Follow @VarunSaxena2

@EmilyWFierce: JAMA: Women face increased risk for second vaginal mesh surgery 10 years after implant. Article | Follow @EmilyWFierce

> The U.S. Drug Enforcement Agency (DEA) has removed the classification of DaTscan (Ioflupane I 123 injection) as a Schedule II controlled substance. GE Healthcare ($GE) markets the imaging agent used to assess the integrity of the striatal dopaminergic system via the dopamine transporter to determine if patients have essential tremor or a parkinsonian syndrome movement disorder such as Parkinson's disease. More

> Olympus has launched the CleverCut3V Distal Wireguided sphincterotome, which it said may be safer and more effective than existing options. More

> Terumo has invested an undisclosed amount in Dutch radioembolization imaging startup Quirem Medical. More

Biotech News

@FierceBiotech: FierceBiotech radio on GSK's latest setback, Kyle Bass' 'truthful irrelevancy,' and Horizon's web presence. More | Follow @FierceBiotech

@JohnCFierce: Four years after a transatlantic slapdown, Merck KGaA will once again seek cladribine OK. Article | Follow @JohnCFierce

@DamianFierce: I hereby endorse this bold, disruptive approach to the language of innovation. More | Follow @DamianFierce

> Lilly upsizes its new Cambridge, MA, R&D shop as Big Pharma crowds the neighborhood. Report

> Soon-Shiong's NantCell hauls in another $100M for immuno-oncology R&D. Story

> FDA advisers side against Purdue's new painkiller, citing dosing dangers. Article

Pharma News

@FiercePharma: USDA, poultry producers warn MN officials to expect bird flu resurgence. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Sun targets Ranbaxy plant in Ireland as it prepares to trim manufacturing network. Article | Follow @EricPFierce

@CarlyHFierce: This date last year, I saved a story on my computer as "GSK Woes." So basically, not much has changed. | Follow @CarlyHFierce

> Boehringer's Ofev, chasing a Roche rival, wins backing from NICE. Story

> AstraZeneca picks up discarded Amgen plant as part of its biologics expansion. Report

> AbbVie scores FDA approval for expanded Humira label. Article